EPAS1 and breast cancer: In previous studies, our research group confirmed that the abnormal expression of endothelial PAS domain-containing protein 1 (EPAS1) is related to the proliferation, invasion, and angiogenesis of breast cancer, and participates in the chemoresistance of this cancer.